GLP1R and chronic kidney disease: In fact, there is evidence that SGLT2i prevents both CKD and HF in people with T2DM while GLP-1 RA prevents CKD and CVD (mainly ischemic heart disease) in overweighted/obese or T2DM populations [9,10,32].